Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 54.15 ($0.69) and last traded at GBX 55 ($0.70), with a volume of 22448 shares trading hands. The stock had previously closed at GBX 57.80 ($0.74).
Celadon Pharmaceuticals Stock Performance
The company has a current ratio of 2.62, a quick ratio of 6.97 and a debt-to-equity ratio of 148.29. The company has a market cap of £36.16 million, a PE ratio of -392.86 and a beta of -0.02. The business has a fifty day moving average of GBX 73.70 and a 200-day moving average of GBX 89.60.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Retail Stocks Investing, Explained
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- EV Stocks and How to Profit from Them
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- How Technical Indicators Can Help You Find Oversold Stocks
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
